Treatment of functional GI disease: the complex pharmacology of serotonergic drugs. Reply from author

作者: Robin Spiller

DOI: 10.1046/J.1365-2125.2002.01702.X

关键词:

摘要: I thank Drs De Ponti & Crema [1] for their interest and valuable comments, which help to clarify some evolving concepts. would entirely agree that while cisapride can induce atrial tachycardia acting via cardiac 5-HT4 receptors, this is not the main cause of cardiotoxicity delayed repolarization muscle as shown by prolongation QT interval. As they have pointed out, several recent publications confirmed mechanism responsible likely be cisapride's action on human ether-a-go-go-related gene (HERG) product, rapidly activating delayed-rectifier K+ current in muscle. Mutations been associated with long [2] susceptibility induced arrthymias [3]. The HERG channel cavity lined aromatic residues, a feature distinguishes it from other channels. This appears render particularly susceptible drug interaction [4]. make very important point directly related receptor agonist properties, (tegaserod, mozapride) appear free effect [5]. I also like them correcting unintentional description buspirone 5-HT1p agonist. am further grateful drawing our attention work, suggests fundal relaxing sumatripan may mediated 5-HT1b/d receptors. encouraging since there are numerous agonists now development migraine market well value gastroenterologists.

参考文章(5)
Fabrizio De Ponti, Francesca Crema, Treatment functional GI disease: the complex pharmacology of serotonergic drugs British Journal of Clinical Pharmacology. ,vol. 54, pp. 680- 680 ,(2002) , 10.1046/J.1365-2125.2002.01703.X
Thierry Bouyssou, Franck Potet, Denis Escande, Isabelle Baró, Gastrointestinal Prokinetic Drugs have Different Affinity for the Human Cardiac Human Ether-à-gogo K+ Channel Journal of Pharmacology and Experimental Therapeutics. ,vol. 299, pp. 1007- 1012 ,(2001)
PETER J. SCHWARTZ, ARTHUR M. BROWN, ELENA RONCHETTI, LAURA BIANCHI, ALDO PINNAVAIA, GIOVANNI ACQUARO, SILVIA G. PRIORI, CARLO NAPOLITANO, Evidence for a Cardiac Ion Channel Mutation Underlying Drug‐Induced QT Prolongation and Life‐Threatening Arrhythmias Journal of Cardiovascular Electrophysiology. ,vol. 11, pp. 691- 696 ,(2000) , 10.1111/J.1540-8167.2000.TB00033.X
Jamie I. Vandenberg, Bruce D. Walker, Terence J. Campbell, HERG K+ channels: friend and foe Trends in Pharmacological Sciences. ,vol. 22, pp. 240- 246 ,(2001) , 10.1016/S0165-6147(00)01662-X
Mark E Curran, Igor Splawski, Katherine W Timothy, G.Michael Vincen, Eric D Green, Mark T Keating, A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome Cell. ,vol. 80, pp. 795- 803 ,(1995) , 10.1016/0092-8674(95)90358-5